Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs031240104Recruiting
Open-label, single-arm trial of tolvaptan in heart failure (HF). Primary endpoint: Change in body weight at 14 days. Started Dec 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs031240104.